Temporary effect of arsenic trioxide treatment of refractory extragonadal germ cell cancer.
Kälkner
Karl Mikael
KM
Ullén
Anders
A
Wersäll
Peter
P
Cohn-Cedermark
Gabriella
G
D000328:Adult; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000494:pharmacology / Q000627:therapeutic use*; D017809:Fatal Outcome; D006801:Humans; D008297:Male; D009373:Neoplasms, Germ Cell and Embryonal / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery; D010087:Oxides / Q000494:pharmacology / Q000627:therapeutic use*; D011379:Prognosis; D013997:Time Factors; D017211:Treatment Failure
D000970:Antineoplastic Agents; D001152:Arsenicals; D010087:Oxides; D000077237:Arsenic Trioxide